These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 568750)
1. The occurrence, specificity, and role of neuroelectric blocking factors in multiple sclerosis. Schauf CL; Davis FA Neurology; 1978 Sep; 28(9 Pt 2):34-9. PubMed ID: 568750 [No Abstract] [Full Text] [Related]
3. Neural blocking activity of multiple sclerosis and EAE sera. Davis FA; Schauf CL Neurology; 1976 Jun; 26(6 PT 2):43-4. PubMed ID: 1083963 [No Abstract] [Full Text] [Related]
4. Neuroelectric blocking factors in human and animal sera evaluated using the isolated frog spinal cord. Schauf CL; Davis FA; Sack DA; Reed BJ; Kesler RL J Neurol Neurosurg Psychiatry; 1976 Jul; 39(7):680-5. PubMed ID: 1086889 [TBL] [Abstract][Full Text] [Related]
8. [Correlation between protein changes in the cerebrospinal fluid and the level of measles antibodies in patients with multiple sclerosis]. Wajgt A; BogaczyĆska E; Zgorzalewicz B Neurol Neurochir Pol; 1974; 8(5):645-52. PubMed ID: 4215045 [No Abstract] [Full Text] [Related]
9. [State of measles immunity in mulitple sclerosis]. Atanadze SN Vopr Virusol; 1978; (3):259-67. PubMed ID: 695518 [No Abstract] [Full Text] [Related]
10. Measles-virus-specific IgG in optic neuritis and in multiple sclerosis after optic neuritis. Hutchinson WM; Haire M Br Med J; 1976 Jan; 1(6001):64-6. PubMed ID: 1244936 [TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis: etiologic and diagnostic significance of measles virus antibodies in the cerebrospinal fluid and serum. Cendrowski W; Niedzielska K Schweiz Arch Neurol Neurochir Psychiatr; 1974; 114(2):215-28. PubMed ID: 4421491 [No Abstract] [Full Text] [Related]
15. Immunoglobulins and measles antibodies in optic neuritis. Link H; Norrby E; Olsson JE N Engl J Med; 1973 Nov; 289(21):1103-7. PubMed ID: 4356853 [No Abstract] [Full Text] [Related]
16. Physiologic basis for neuroelectric blocking activity in multiple sclerosis. Schauf CL; Pencek TL; Davis FA; Rooney MW Neurology; 1981 Oct; 31(10):1337-41. PubMed ID: 6287352 [No Abstract] [Full Text] [Related]
17. [Evaluation of the occurrence and properties of measles virus antibodies by the ELISA method]. Jankowski M Med Dosw Mikrobiol; 1986; 38(1):23-30. PubMed ID: 3713367 [No Abstract] [Full Text] [Related]
18. Use of a radioimmune assay in detection of measles antibodies in cerebrospinal fluid and serum. Good RA Acta Neurol Scand Suppl; 1977; 63():199-206. PubMed ID: 265667 [TBL] [Abstract][Full Text] [Related]
19. [Serum and cerebrospinal fluid antibodies against measles virus in patients with multiple sclerosis]. Ferrante P; Caputo D; Fasan M; Barbesti S Arch Sci Med (Torino); 1982; 139(1):39-43. PubMed ID: 7103707 [TBL] [Abstract][Full Text] [Related]
20. Intra-blood-brain barrier measles virus antibody synthesis in multiple sclerosis patients. Albrecht P; Tourtellotte WW; Hicks JT; Sato H; Boone EJ; Potvin AR Neurology; 1983 Jan; 33(1):45-50. PubMed ID: 6681559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]